Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ analysis
Cell Proliferation
Diagnosis, Differential
Diagnostic Errors
Europe
Female
Humans
Lymphoma, B-Cell, Marginal Zone
/ immunology
Lymphoma, T-Cell, Peripheral
/ immunology
Male
Middle Aged
North America
Predictive Value of Tests
Programmed Cell Death 1 Receptor
/ analysis
T-Lymphocytes, Helper-Inducer
/ immunology
Tumor Microenvironment
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
26
11
2019
medline:
29
7
2020
entrez:
26
11
2019
Statut:
ppublish
Résumé
The diagnosis of nodal marginal zone lymphoma (NMZL) can be challenging, with the differential diagnosis including other low-grade B-cell lymphomas, reactive hyperplasia, and even some cases of peripheral T-cell lymphoma (PTCL). PTCL may have a perifollicular growth pattern mimicking NMZL. We and others have noted an atypical distribution of T-follicular helper (TFH) cells in some cases of NMZL. This study was prompted by the diagnosis of NMZL in several cases in which a marked increase of TFH cells, as determined by staining for programmed death-1 (PD1), had prompted suspicion for a diagnosis of PTCL. We analyzed PD1 staining in 48 cases of NMZL to characterize the extent and pattern of the PD1-positive infiltrate. Three main patterns of PD1 staining were identified: follicular pattern (peripheral, n=16; central, n=9; mixed, n=3), diffuse pattern (n=4), and a reduced or normal staining pattern in residual follicles (n=16). A comprehensive analysis of other TFH markers was undertaken in 14 cases with a high content of PD1-positive cells that were confirmed as B-cell lymphoma by clonality analysis. We describe in detail 5 of these cases in which PTCL was an initial consideration. This study illuminates the diverse immunohistochemical patterns encountered in NMZL and highlights a diagnostic pitfall important for diagnostic accuracy.
Identifiants
pubmed: 31764221
doi: 10.1097/PAS.0000000000001414
pii: 00000478-202005000-00010
pmc: PMC8189156
mid: NIHMS1699204
doi:
Substances chimiques
Biomarkers, Tumor
0
PDCD1 protein, human
0
Programmed Cell Death 1 Receptor
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
657-664Subventions
Organisme : Intramural NIH HHS
ID : Z01 SC000550
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
J Mol Diagn. 2003 May;5(2):82-7
pubmed: 12707372
Histopathology. 2019 Aug;75(2):287-290
pubmed: 30860612
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Haematologica. 2013 Jul;98(7):1003-13
pubmed: 23813646
Virchows Arch. 2006 Jul;449(1):78-87
pubmed: 16633785
Pathol Int. 2002 May-Jun;52(5-6):400-5
pubmed: 12100523
Am J Surg Pathol. 2001 Mar;25(3):395-400
pubmed: 11224611
J Clin Pathol. 1992 Sep;45(9):770-5
pubmed: 1401205
Am J Surg Pathol. 2007 Sep;31(9):1310-22
pubmed: 17721185
Nat Rev Immunol. 2018 Mar;18(3):153-167
pubmed: 28990585
Mod Pathol. 2009 Jun;22(6):753-61
pubmed: 19329936
Histopathology. 2013 Oct;63(4):482-98
pubmed: 23855758
Am J Surg Pathol. 1999 Jan;23(1):59-68
pubmed: 9888704
Pathobiology. 2010;77(1):24-7
pubmed: 20185964
Am J Surg Pathol. 2010 Feb;34(2):178-89
pubmed: 20087161
Am J Surg Pathol. 2000 Jan;24(1):117-22
pubmed: 10632495
Am J Surg Pathol. 2010 Oct;34(10):1425-35
pubmed: 20871216
Am J Surg Pathol. 2006 Jul;30(7):802-10
pubmed: 16819321
Hum Pathol. 1994 Dec;25(12):1269-75
pubmed: 8001920
Mod Pathol. 2002 Apr;15(4):420-5
pubmed: 11950916
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Am J Surg Pathol. 2007 Jul;31(7):1077-88
pubmed: 17592275
J Clin Oncol. 2013 Jan 10;31(2):e28-30
pubmed: 23213091